Your SlideShare is downloading. ×
0
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
3 Humongous Healthcare Stocks This Week   4-4-14
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

3 Humongous Healthcare Stocks This Week 4-4-14

4,578

Published on

The biggest winners in all of healthcare over the last week

The biggest winners in all of healthcare over the last week

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
4,578
On Slideshare
0
From Embeds
0
Number of Embeds
8
Actions
Shares
0
Downloads
4
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide
  • http://www.fool.com/investing/general/2014/02/04/why-furiex-pharmaceuticals-inc-shares-furiously-do.aspx
  • http://finance.yahoo.com/news/athenahealth-surges-stronger-expected-4q-181446268.html
  • http://finance.yahoo.com/news/ohr-pharmaceutical-present-16th-annual-131500941.html
  • http://investor.furiex.com/releasedetail.cfm?ReleaseID=822849
  • Transcript

    • 1. 3 Humongous Health-Care Stocks This Week
    • 2. The old adage says that April showers bring May flowers. However, at least three health-care stocks blossomed big-time in the first few weeks of April. Here are your most humongous health-care winners over the past week. Source: Wikimedia Commons
    • 3. Shares of the biotech skyrocketed 42% this week. MannKind Corporation (Nasdaq: MNKD) Source: Yahoo! Finance
    • 4. • An FDA advisory committee recommended approval of Afrezza. • The vote for recommending approval for the inhaled insulin in treating type 1 diabetes was 13- 1, while the vote on type 2 diabetes was 14-0. • The FDA is scheduled to make its decision by April 15. Why MannKind took a giant leap
    • 5. Shares of the molecular diagnostics company jumped nearly 25% this week. Myriad Genetics (Nasdaq: MYGN) Source: Yahoo! Finance
    • 6. • Medicare reimbursements for genetic breast cancer tests were upped 52% above earlier proposed pricing. • Myriad’s BRACAnalysis test is a direct beneficiary of the government’s surprising change. • Japanese financial firm Mizuhu quickly upgraded Myriad’s stock from a “neutral” rating to “buy.” Why Myriad Genetics moved ginormously
    • 7. Shares of the robotic surgical systems maker climbed 18% higher for the week. Intuitive Surgical (Nasdaq: ISRG) Source: Yahoo! Finance
    • 8. • The FDA cleared Intuitive’s new da Vinci Xi surgical system. • The new system should greatly expand the types of surgeries that can be performed. • Investment firm William Blair raised its estimate of the potential market size for Intuitive’s products by 44% in response to the FDA decision. Why Intuitive Surgical surged
    • 9. • While Myriad Genetics and Intuitive Surgical could do very well in 2014, my pick from this week’s best health-care stocks is MannKind. • It’s been a long time coming, but MannKind appears to now have a great shot at gaining FDA approval for Afrezza. • If the biotech lines up a solid partner to market the inhaled insulin, this stock could be one of the biggest winners of the year. • Downside risks remain -- the FDA might not grant approval; a partner might not be found; Afrezza might not take off as the company hopes. • Overall, though, MannKind’s chances of sustained success seem pretty good. Best pick to stay humongous?
    • 10. Find out which stock The Motley Fool’s chief investment officer selected as the top pick for 2014 in our free report!

    ×